Novartis to Close UK R&D Site
Novartis has confirmed that it will cease all operations at its Horsham, UK site by late June.
The site, a Novartis "Institute for Biomedical Research," employs around 400 people.
The site closing is part of Novartis's global efforts to re-align resources and co-locate research teams.